Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Revenues:        
Revenues $ 1,509,453 $ 1,119,898 $ 2,922,867 $ 2,213,158
Costs and expenses:        
Costs of revenues 633,618 408,260 1,237,859 789,647
Research and development 220,751 165,903 431,331 319,433
Selling, general and administrative 192,253 112,462 380,598 226,900
Interest expense 40,472 26,538 80,822 52,900
Other expense (income), net (2,568) (9,228) (4,186) (19,253)
Income before income taxes 424,927 415,963 796,443 843,531
Provision for income taxes 44,622 46,863 69,742 78,487
Net income 380,305 369,100 726,701 765,044
Less: Net loss attributable to non-controlling interest (250) 0 (379) 0
Net income attributable to KLA $ 380,555 $ 369,100 $ 727,080 $ 765,044
Net income per share attributable to KLA        
Basic (in dollars per share) $ 2.42 $ 2.43 $ 4.60 $ 4.98
Diluted (in dollars per share) $ 2.40 $ 2.42 $ 4.56 $ 4.96
Weighted-average number of shares:        
Basic (in shares) 157,290 152,148 157,994 153,684
Diluted (in shares) 158,620 152,648 159,314 154,389
Product        
Revenues:        
Revenues $ 1,144,550 $ 852,201 $ 2,202,525 $ 1,681,428
Service        
Revenues:        
Revenues $ 364,903 $ 267,697 $ 720,342 $ 531,730